Kent, A; Makwana, A; Sheppard, CL; Collins, S; Fry, NK; Heath, PT; Ramsay, M; Ladhani, SN
(2019)
Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post–13-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now?
Clin Infect Dis, 69 (1).
pp. 84-90.
ISSN 1537-6591
https://doi.org/10.1093/cid/ciy842
SGUL Authors: Heath, Paul Trafford
![[img]](https://openaccess.sgul.ac.uk/110260/1.hassmallThumbnailVersion/ciy842.pdf) ![](https://openaccess.sgul.ac.uk/110260/1.haspreviewThumbnailVersion/ciy842.pdf) Preview |
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined].
Download (649kB)
| Preview
|
Abstract
Background
Invasive pneumococcal disease (IPD) has declined significantly since the introduction of pneumococcal conjugate vaccines (PCVs). It is not known whether certain infant populations remain at higher risk of IPD in countries with established 13-valent PCV (PCV13) programs. We aimed to describe the epidemiology, clinical characteristics, serotype distribution, and outcomes of IPD in infants, and to estimate the relative risk of PCV13-type, non-PCV13-type, and overall IPD in premature infants compared to term infants during a 4-year period after the PCV13 program was established.
Methods
This was a prospective, enhanced national surveillance of laboratory-confirmed IPD in England in infants aged <1 year diagnosed during 2013–2016.
Results
There were 517 cases of IPD (incidence: 19/100000 infants). Incidence was significantly higher in premature infants compared with those born at term (49/100000 vs 17/100000; incidence rate ratio [IRR], 2.87; P < .001), with infants born before 28 weeks’ gestation having the highest incidence (150/100000; IRR, 8.8; P < .001). Of the 454 IPD cases with serotyped isolates, most were caused by non-PCV13 serotypes (369 cases, 71.4%), with 85 cases (16.4%) due to PCV13 serotypes. There were 31 deaths (case fatality rate [CFR], 6.2% [95% confidence interval, 4.3%–8.6%]). Premature infants did not have a higher CFR than term infants (P = .62).
Conclusions
IPD incidence in infants remains lower than rates reported prior to PCV7 introduction in England. The risk of IPD remains significantly higher in premature infants compared to infants born at term, for both PCV13 and non-PCV13 serotypes. Any changes to the infant PCV13 immunization schedule may disproportionally affect premature infants.
Item Type: |
Article
|
Additional Information: |
This is a pre-copyedited, author-produced version of an article accepted for publication in Clinical Infectious Diseases following peer review. The version of record Alison Kent, Ashley Makwana, Carmen L Sheppard, Sarah Collins, Norman K Fry, Paul T Heath, Mary Ramsay, Shamez N Ladhani, Invasive Pneumococcal Disease in UK Children <1 Year of Age in the Post–13-Valent Pneumococcal Conjugate Vaccine Era: What Are the Risks Now?, Clinical Infectious Diseases, Volume 69, Issue 1, 1 July 2019, Pages 84–90 is available online at: https://doi.org/10.1093/cid/ciy842 |
Keywords: |
06 Biological Sciences, 11 Medical And Health Sciences, Microbiology |
SGUL Research Institute / Research Centre: |
Academic Structure > Infection and Immunity Research Institute (INII) |
Journal or Publication Title: |
Clin Infect Dis |
ISSN: |
1537-6591 |
Language: |
eng |
Dates: |
Date | Event |
---|
1 July 2019 | Published | 3 October 2018 | Published Online | 28 September 2018 | Accepted |
|
Publisher License: |
Publisher's own licence |
PubMed ID: |
30281069 |
![](http://static.pubmed.gov/portal/portal3rc.fcgi/2745237/img/27842) |
Go to PubMed abstract |
URI: |
https://openaccess.sgul.ac.uk/id/eprint/110260 |
Publisher's version: |
https://doi.org/10.1093/cid/ciy842 |
Statistics
Item downloaded times since 12 Oct 2018.
Actions (login required)
![Edit Item](/style/images/action_view.png) |
Edit Item |